Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Competition critic

Executive Summary

From the Republican side, Oklahoma Rep. Coburn continued his recent attacks on drug pricing and competition. Restricted to one minute by the majority, Coburn charged that the debate was on the wrong subject. "What we are doing is the wrong thing," Coburn said. "The politics of Washington is claiming to fix a problem that is very real, but it is fixing the wrong problem. The problem is there is no competition within the pharmaceutical industry"
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS036292

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel